United Kingdom

Immutep Ltd (IMMP.OQ)

IMMP.OQ on NASDAQ Stock Exchange Global Market

8:59pm GMT
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Prima Biomed says Lucy Turnbull steps down as chairman​
Thursday, 16 Nov 2017 

Nov 17 (Reuters) - Prima Biomed Ltd ::Russell Howard appointed as chairman​.Lucy Turnbull steps down as chairman​.‍vice-Chairman Albert Wong to step down​.  Full Article

Prima Biomed files for offer and sale of up to 197.35 mln ordinary shares
Thursday, 19 Oct 2017 

Oct 20 (Reuters) - Prima Biomed Ltd :Prima Biomed Ltd files for offer and sale of up to 197.35 million ordinary shares, represented by 1.97 million adss‍​ by selling shareholders - SEC filing.  Full Article

Prima Biomed ‍received approval for intiation of ‘Insight’ clinical trial
Monday, 10 Jul 2017 

July 10 (Reuters) - Prima Biomed Ltd :Received regulatory and ethical approvals for clinical trial investigating IMP321 in new settings, called Insight​.Approval has been received from Paul-Ehrlich-Institut, Federal Institute For Vaccines And Biomedicines For German Federal Ministry Of Health.  Full Article

Prima Biomed enters agreement with Sydys to advance CVac Program
Thursday, 12 May 2016 

Prima BioMed Ltd : PRR enters agreement with Sydys to Advance Cvac Program . In the spin out transaction Prima will receive a 9.9% equity stake in sydys at closing as consideration for the assets being transferred . Prima could receive over A$400 million for achievement of set commercial sales targets, in addition to single digit royalties on sales .  Full Article

BRIEF-Immutep Says ‍H1 Net Loss Attributable $4.3 Million

* ‍H1 NET LOSS ATTRIBUTABLE $4.3 MILLION VERSUS LOSS OF $4.1 MILLION A YEAR AGO​ Source text for Eikon: Further company coverage: